Vimarsana
Biggest News Aggregation in the World

Page 5 - Timothy Ko News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timothy Ko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timothy Ko Today - Breaking & Trending Today

Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments - Vimarsana News

Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments "Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides an update on license amendments issued to its clinical research organization, The Centre for Human Drug Research (CHDR). Entheon confirms that the CHDR, the Company's Netherlands-based partner clinical research organization, has received an amendment to its opioid license, enabling it to possess and conduct research with DMT. The opioid license amendment ...

AbbVie (ABBV), COMP SERVICES (CMPS), Entheon Biomedical (ENTBF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd. (FTRPF), HAVN Life Sciences (HAVLF), Johnson & Johnson (JNJ), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC. (MYCOF), Psyched Wellness (PSYCF), Seelos Therapeutics, Inc. - Common Stock (SEEL), RED LIGHT HOLLAND CORP by Red Light Holland Corp. (TRUFF) - First Psychedelics ETF Debuts On NEO Exchange - Vimarsana News

AbbVie (ABBV), COMP SERVICES (CMPS), Entheon Biomedical (ENTBF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd. (FTRPF), HAVN Life Sciences (HAVLF), Johnson & Johnson (JNJ), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC. (MYCOF), Psyched Wellness (PSYCF), Seelos Therapeutics, Inc. - Common Stock (SEEL), RED LIGHT HOLLAND CORP by Red Light Holland Corp. (TRUFF) - First Psychedelics ETF Debuts On NEO Exchange

Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first exchange traded fund providing exposure to the burgeoning industry of medicinal psychedelics. The ETF is managed by Horizons ETFs Management, a Canadian ETF firm that’s part of the portfolio of Mirae Assets. In 2017, Horizons released the Marijuana Life Sciences Index ETF (TSX:HMMJ), cannabis’ longest running ETF. "PSYK will give investors exposure to the leading public companies undertaking this important research and development of treatments for the more t...

Entheon Biomedical Corp.: Entheon Biomedical to be Included in First North American Psychedelic ETF - Vimarsana News

Entheon Biomedical Corp.: Entheon Biomedical to be Included in First North American Psychedelic ETF

Entheon Biomedical Corp.: Entheon Biomedical to be Included in First North American Psychedelic ETF Vancouver, British Columbia--(Newsfile Corp. - January 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) ( "Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce its inclusion in the Horizon North American Psychedelic ETF, the first ever psychedelic ETF of its kind. The new ETF is expected to start trading January 26, 2021 under the symbol "PYSK" on the NEO exchange. The Psychedeli...

KCSA Strategic Communications Announces Agenda for the KCSA Psychedelics Investor Conference on January 26-27, 2021 - Vimarsana News

KCSA Strategic Communications Announces Agenda for the KCSA Psychedelics Investor Conference on January 26-27, 2021

Webcast Information To attend the live video webcast, please register or email KCSA Strategic Communications at [email protected]. About KCSA Strategic Communications KCSA is a fully integrated communications agency specializing in public relations, shareholder communications and social media, with expertise in financial and professional services, technology, healthcare, digital media, cannabis and energy. Since 1969, the Firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The Firm's ...

Entheon Biomedical Corp.: Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development - Vimarsana News

Entheon Biomedical Corp.: Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) ("Entheon" or the "Company"), a biotechnology company focused on